Data as of Oct 24
| +0.77 / +1.11%|
The 28 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 72.14, with a high estimate of 94.20 and a low estimate of 47.82. The median estimate represents a +2.88% increase from the last price of 70.12.
The current consensus among 30 polled investment analysts is to Hold stock in AstraZeneca PLC. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.